References
- ACOG. 2001. Practice Bulletin 28: Clinical management guidelines for obstetrician-gynecologists. Use of botanicals for management of menopausal symptoms. Obstetrics and Gynecology 97(Suppl 1):11.
- Bergeron C, Amant F, Ferenczy A. 2006. Pathology and physiopathology of adenomyosis. Best Practice and Research. Clinical Obstetrics and Gynaecology 20:511–521.
- Borrelli F, Ernst E. 2008. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. American Journal of Obstetrics and Gynecology 199:455–466.
- Huntley A, Ernst E. 2003. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 10:465–476.
- Koshiyama M, Okamoto T, Ueta M. 2004. The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri. Cancer Detection and Prevention 28:94–98.
- Longacre TA, Hendrikson MR. 1999. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. American Journal of Surgical Pathology 23:69–78.
- Mandai M. 2009. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. International Journal of Clinical Oncology 14:383–391.
- Murphy PA. 2002. St. John's wort and oral contraceptives: reasons for concern?Journal of Midwifery and Women's Health 47:447–450.
- Roberts H. 2010. Safety of herbal medicinal products in women with breast cancer. Maturitas 66:363–369.
- Takai N, Akizuki S, Naso K et al. 1999. Endometrioid adenocarcinoma arising from adenomyosis. Gynecologic and Obstetric Investigation 48:141–144.